Compare Stocks

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AGL agilon health	$5.56 +3.3%	$5.78	$4.41 ▼ $26.75	$2.28B	0.49	5.82 million shs	247,540 shs
DVA DaVita	$127.73 +1.3%	$130.32	$71.51 ▼ $141.54	$11.20B	1.04	811,882 shs	54,540 shs
PGNY Progyny	$32.62 +2.3%	$36.84	$29.44 ▼ $44.95	$3.14B	1.48	776,210 shs	43,314 shs

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AGL agilon health	+7.49%	+1.03%	-1.55%	-15.60%	-79.73%
DVA DaVita	-1.20%	-4.03%	-8.83%	+20.38%	+50.85%
PGNY Progyny	-2.66%	-8.84%	-12.15%	-14.78%	-6.40%

New crypto project uncovers 2,050% in 65 days (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AGL agilon health	1.1611 of 5 stars	4.1	1.0	0.0	1.1	0.0	0.6
DVA DaVita	3.2944 of 5 stars	1.2	2.0	4.5	2.0	2.5	2.5
PGNY Progyny	4.2297 of 5 stars	4.5	1.0	0.0	2.5	3.3	3.1

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AGL agilon health	2.19	Hold	$9.73	75.01% Upside
DVA DaVita	2.33	Hold	$118.50	-7.23% Downside
PGNY Progyny	3.00	Buy	$48.30	48.07% Upside

Current Analyst Ratings

Latest PGNY, DVA, and AGL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/17/2024	PGNY Progyny	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$46.00
3/6/2024	AGL agilon health	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Underweight	$5.00
3/6/2024	DVA DaVita	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Equal Weight	$133.00
2/29/2024	AGL agilon health	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$13.00 ➝ $9.00
2/29/2024	AGL agilon health	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$10.00 ➝ $7.50
2/28/2024	AGL agilon health	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	In-Line ➝ In-Line	$7.00 ➝ $6.00
2/28/2024	AGL agilon health	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$11.00 ➝ $8.00
2/28/2024	PGNY Progyny	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$48.00
2/28/2024	PGNY Progyny	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$47.00 ➝ $46.00
2/28/2024	PGNY Progyny	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$45.00 ➝ $43.00
2/26/2024	AGL agilon health	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$25.00 ➝ $6.50

(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AGL agilon health	$4.32B	0.53	N/A	N/A	$1.63 per share	3.41
DVA DaVita	$12.14B	0.92	$16.83 per share	7.59	$13.63 per share	9.37
PGNY Progyny	$1.09B	2.88	$0.67 per share	48.80	$5.77 per share	5.65

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AGL agilon health	-$262.60M	-$0.65	N/A	N/A	N/A	-5.76%	-21.74%	-8.89%	5/7/2024 (Confirmed)
DVA DaVita	$691.53M	$7.40	17.26	12.76	1.14	5.70%	64.42%	4.63%	5/2/2024 (Confirmed)
PGNY Progyny	$62.04M	$0.62	52.61	33.63	1.35	5.70%	12.64%	8.82%	5/13/2024 (Estimated)

Latest PGNY, DVA, and AGL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/7/2024	N/A	AGL agilon health	-$0.01	N/A	+$0.01	N/A	N/A	N/A
5/2/2024	N/A	DVA DaVita	$1.96	N/A	-$1.96	N/A	N/A	N/A
2/27/2024	Q4 2023	AGL agilon health	-$0.28	-$0.41	-$0.13	-$0.25	$1.02 billion	$1.06 billion
2/27/2024	Q4 2023	PGNY Progyny	$0.09	$0.13	+$0.04	$0.13	$274.08 million	$269.94 million
2/13/2024	Q4 23	DVA DaVita	$1.53	$1.87	+$0.34	$2.12	$3.01 billion	$3.15 billion

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AGL agilon health	N/A	N/A	N/A	N/A	N/A
DVA DaVita	N/A	N/A	N/A	N/A	N/A
PGNY Progyny	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AGL agilon health	0.05	1.51	1.51
DVA DaVita	6.65	1.19	1.13
PGNY Progyny	N/A	3.44	3.44

Ownership

Institutional Ownership

Company	Institutional Ownership
AGL agilon health	N/A
DVA DaVita	90.12%
PGNY Progyny	94.93%

Insider Ownership

Company	Insider Ownership
AGL agilon health	3.60%
DVA DaVita	1.40%
PGNY Progyny	14.30%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
AGL agilon health	1,117	409.54 million	394.80 million	Not Optionable
DVA DaVita	70,000	87.70 million	86.47 million	Optionable
PGNY Progyny	563	96.11 million	82.37 million	Optionable

PGNY, DVA, and AGL Headlines

Source	Headline
	Progyny (NASDAQ:PGNY) Rating Reiterated by Truist Financial americanbankingnews.com - April 19 at 1:58 AM
	Truist Financial Reaffirms "Buy" Rating for Progyny (NASDAQ:PGNY) marketbeat.com - April 17 at 3:51 PM
	Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care finance.yahoo.com - April 17 at 10:24 AM
	Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care globenewswire.com - April 17 at 9:23 AM
	Progyny, Inc. (PGNY) Interactive Stock Chart - Yahoo Finance finance.yahoo.com - April 16 at 1:52 PM
	Progyny, Inc. (NASDAQ:PGNY) Shares Bought by DekaBank Deutsche Girozentrale marketbeat.com - April 13 at 5:58 AM
	Benjamin Graham Detailed Fundamental Analysis - PGNY nasdaq.com - April 10 at 2:16 PM
	Baillie Gifford & Co. Decreases Holdings in Progyny, Inc. (NASDAQ:PGNY) marketbeat.com - April 10 at 8:34 AM
	International Assets Investment Management LLC Raises Stock Position in Progyny, Inc. (NASDAQ:PGNY) marketbeat.com - April 6 at 7:08 AM
	Progyny CFO sells over $419k in company stock investing.com - April 5 at 4:04 AM
	Progyny executive chairman sells $37,522 in stock investing.com - April 5 at 4:04 AM
	Progyny, Inc. (NASDAQ:PGNY) Shares Sold by Riverbridge Partners LLC marketbeat.com - April 5 at 12:49 AM
	Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast globenewswire.com - April 4 at 8:59 AM
	Progyny, Inc. (NASDAQ:PGNY) Chairman Sells $37,520.00 in Stock insidertrades.com - April 4 at 6:52 AM
	Progyny, Inc. (NASDAQ:PGNY) Given Average Recommendation of "Buy" by Analysts marketbeat.com - April 4 at 2:15 AM
	Insider Sell: President Michael Sturmer Sells Shares of Progyny Inc (PGNY) finance.yahoo.com - April 3 at 9:07 PM
	Progyny, Inc. (NASDAQ:PGNY) Chairman David J. Schlanger Sells 1,000 Shares marketbeat.com - April 3 at 6:58 PM
	Executive Chairman David Schlanger Sells 71,272 Shares of Progyny Inc (PGNY) finance.yahoo.com - March 30 at 8:04 AM
	Progyny, Inc. (NASDAQ:PGNY) Chairman David J. Schlanger Sells 71,272 Shares insidertrades.com - March 30 at 7:15 AM
	Insider Selling: Progyny, Inc. (NASDAQ:PGNY) Chairman Sells 71,272 Shares of Stock marketbeat.com - March 29 at 9:16 PM
	Vanguard Group Inc. Has $277.52 Million Stake in Progyny, Inc. (NASDAQ:PGNY) marketbeat.com - March 29 at 4:18 AM
	Progyny, Inc. (NASDAQ:PGNY) Chairman Sells $97,777.05 in Stock insidertrades.com - March 28 at 8:45 AM
	Executive Chairman David Schlanger Sells Shares of Progyny Inc (PGNY) finance.yahoo.com - March 28 at 3:15 AM
	Fort Washington Investment Advisors Inc. OH Raises Stock Position in Progyny, Inc. (NASDAQ:PGNY) marketbeat.com - March 26 at 11:08 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer
March 24, 2024 1:50 PM
View Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer
3 Stocks Insiders Are Buying That Analysts Love
March 26, 2024 12:55 PM
View 3 Stocks Insiders Are Buying That Analysts Love
Unusually High Volume Points to Upside in These Stocks
April 5, 2024 7:45 AM
View Unusually High Volume Points to Upside in These Stocks
The 5 Stocks Most Sold By Insiders This Year
April 16, 2024 10:45 AM
View The 5 Stocks Most Sold By Insiders This Year

All Headlines

Company Descriptions

agilon health

NYSE:AGL

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

DaVita

NYSE:DVA

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Progyny

NASDAQ:PGNY

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial